Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukaemia (AML) are frequent. It have been shown that some splicing variants had a prognostic value in AML.
AML are characterized by their propensity to relapse because of the persistence of leukaemia initiating cells (LICs).
The aim of this study is to determine the splice variants on AML initiator cells and define a splicing pattern.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Splicing variants | Sample of acute myeloid leukaemia primary cells |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Assessment of splicing variants | Other | This is a biological study with primary samples without any intervention on patients. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Polymerase chain reaction | Transcriptome analysis to determine the splicing variants on acute myeloid leukaemia initiator cells. The analysis will focus on the gene encoding ABCA3 transporter and genes known to be mutated in patients with acute myeloid leukemia (FLT3, NPM1, c-Kit, N et K-RAS). The duration of selection of samples is estimated to be one month. | 1 month |
| Ribonucleic acid sequencing | Transcriptome analysis to determine the splicing variants on acute myeloid leukaemia initiator cells. The analysis will focus on the gene encoding ABCA3 transporter and genes known to be mutated in patients with acute myeloid leukemia (FLT3, NPM1, c-Kit, N et K-RAS). The duration of selection of samples is estimated to be one month. | 1 month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
None
Not provided
Not provided
Not provided
Patients with 11q23 acute myeloid leukaemia
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Etienne PAUBELLE, MD, PhD | Contact | 04 78 86 22 50 | +33 | Etienne.paubelle@chu-lyon.fr |
| Eric WATTEL, MD, PhD | Contact | 04 78 86 22 60 | +33 | eric.wattel@chu-lyon.fr |
| Name | Affiliation | Role |
|---|---|---|
| Etienne PAUBELLE, MD, PhD | Service d'hématologie du Centre Hospitalier Lyon Sud | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Service d'hématologie du Centre Hospitalier Lyon Sud | Recruiting | Pierre-Bénite | 69310 | France |
Not provided
| ID | Term |
|---|---|
| D015470 | Leukemia, Myeloid, Acute |
| ID | Term |
|---|---|
| D007951 | Leukemia, Myeloid |
| D007938 | Leukemia |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
RNA
| D006402 |
| Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |